Why Sickle Cell Care Should Be Approached Differently

Because every patient—and every sickle cell crisis—can be vastly different.
Care needs be tailored to the individual rather than following a one-size-fits-all approach.

Every Patient Is Different

Sickle cell disease affects everyone differently. Patients with the same diagnosis, and even similar clinical findings, may experience very different symptoms, complications and treatment needs.

  • The same genotype can result in very different disease severity.
  • Similar blood results do not always reflect how unwell a patient feels.
  • Pain varies between individuals and even between crises in the same patient.
  • The frequency, severity and location of pain can change over time.
  • Some patients experience frequent vaso-occlusive crises, while others primarily experience chronic pain or organ complications.
  • Triggers for pain and complications differ from person to person.
  • Previous treatment response is often a better guide than assumptions based on investigations alone.
  • People living with sickle cell often develop a detailed understanding of their own condition and what treatments work best for them.

Key takeaway

Every patient should be assessed as an individual rather than compared with previous patients or expected disease patterns.

The Condition Is Complex

Sickle cell disease is a lifelong, multisystem condition that can affect almost every organ in the body. Clinical presentation is often more complex than it first appears.

  • Sickle cell is not simply a blood disorder - it can affect almost every organ system.
  • Acute and chronic complications frequently coexist.
  • Pain is only one aspect of the condition.
  • Symptoms may overlap with other common conditions, making assessment more challenging.
  • A patient presenting with pain may also be developing another serious complication.
  • Serious complications can develop rapidly and may not always be obvious during the initial assessment.
  • Patients may appear clinically well despite experiencing severe pain or developing significant complications.
  • Effective care requires consideration of the whole patient rather than focusing solely on pain management.

Key takeaway

Sickle cell care requires careful assessment, clinical judgement and an awareness that symptoms may not always reflect the underlying severity of disease.

There Is Still Much More To Learn

Although knowledge and treatment continue to improve, important evidence gaps remain. Continued research, education and listening to patient experiences are essential to improving care.

  • Sickle cell disease has historically received less attention and investment than many other long-term conditions.
  • There are still important gaps in understanding why disease severity varies so widely between patients.
  • More research is needed into lived experience, long-term outcomes and healthcare inequalities.
  • UK reports continue to identify low awareness of sickle cell among healthcare professionals.
  • Patients continue to report stigma, bias and inconsistent experiences of care.
  • Education and training remain key priorities for improving patient outcomes.
  • Listening to patient experiences is essential for shaping better services and improving clinical practice.
  • As research evolves, healthcare professionals should continue updating their knowledge and practice.

Key takeaway

Understanding sickle cell disease continues to evolve. Remaining open to new evidence, patient insight and ongoing learning is essential to delivering better care.

Sources

A Rapid Evidence Assessment of Sickle Cell Disease Educational Interventions (Journal of Clinical Nursing, 2023)

Genetic Basis of Heterogeneity and Severity in Sickle Cell Disease (Experimental Biology and Medicine, 2016)

Top Priorities for Research Established Across Sickle Cell and Genomics (2025)

NICE CG143 – Sickle Cell Disease: Managing Acute Painful Episodes in Hospital

No One's Listening – APPG Inquiry (2021)